MCF Advisors’s CryoPort CYRX Stock Holding History

MCF Advisors’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.99K	Hold	445	–	–	﹤0.01%	1116
2026 Q1	$3.69K	Hold	445	–	–	﹤0.01%	1134
2025 Q4	$4.27K	Hold	445	–	–	﹤0.01%	972
2025 Q3	$4.22K	Buy	+445	New	+$3.75K	﹤0.01%	819
2022 Q4	–	Sell	-149	Closed	-$4K	–	834
2022 Q3	$4K	Buy	+149	New	+$5.13K	﹤0.01%	628

Other funds holding CYRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

MCF Advisors's CYRX Position: Q2 2026 in Review

MCF Advisors held its CryoPort (CYRX) position steady in Q2 2026 at 445 shares worth $6.99K. The position accounts for ﹤0.01% of the portfolio, ranked #1116.

MCF Advisors first reported a position in CYRX in Q3 2022 and has held it in 5 quarters since. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

MCF Advisors held 445 shares of CryoPort worth $6.99K as of Q2 2026.
MCF Advisors left its CryoPort share count unchanged in Q2 2026.
CryoPort made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #1116 holding.
MCF Advisors first reported a position in CryoPort in Q3 2022 and has held it in 5 quarters since.
185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.